Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Goldberg

Showing results (1-10 of 357) with videos related to

Pageof 36
Sort By:
The Oncologist|October 13, 2006
Therapy for metastatic colorectal cancerRichard M Goldberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2005
Intensive surveillance after stage II or III colorectal cancer: is it worth it?Richard M Goldberg
Clinical Colorectal Cancer|November 28, 2002
N9741: a phase III study comparing irinotecan to oxaliplatin-containing regimens in advanced colorectal cancerRichard M Goldberg
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Evolving therapy and management of metastatic colon cancerRichard M Goldberg
Gastrointestinal Cancer Research : GCR|April 11, 2009
Which strategies will lead to progress in the management of colorectal cancer?Richard M Goldberg
Onkologie|June 5, 2010
Strategic options on behalf of patients with metastatic colorectal cancer: mass tumor murder versus serial tumor killingRichard M Goldberg
Onkologie|June 4, 2005
Lessons learned from the edrecolomab story: how a checkered past became a checkered flag for monoclonal antibodies in colorectal cancer therapyRichard M Goldberg
The Oncologist|October 30, 2015
Genomic Profiling in Gastrointestinal Cancer: Are We Ready To Use These Data to Make Treatment Decisions?Richard M Goldberg
Clinical Colorectal Cancer|June 24, 2004
Current approaches to first-line treatment of advanced colorectal cancerRichard M Goldberg
Nature Reviews. Drug Discovery|June 21, 2005
CetuximabRichard M Goldberg
Pageof 36

Showing results (1-10 of 357) with videos related to

Sort By:
Pageof 36
The Oncologist|October 13, 2006
Therapy for metastatic colorectal cancerRichard M Goldberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2005
Intensive surveillance after stage II or III colorectal cancer: is it worth it?Richard M Goldberg
Clinical Colorectal Cancer|November 28, 2002
N9741: a phase III study comparing irinotecan to oxaliplatin-containing regimens in advanced colorectal cancerRichard M Goldberg
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Evolving therapy and management of metastatic colon cancerRichard M Goldberg
Gastrointestinal Cancer Research : GCR|April 11, 2009
Which strategies will lead to progress in the management of colorectal cancer?Richard M Goldberg
Onkologie|June 5, 2010
Strategic options on behalf of patients with metastatic colorectal cancer: mass tumor murder versus serial tumor killingRichard M Goldberg
Onkologie|June 4, 2005
Lessons learned from the edrecolomab story: how a checkered past became a checkered flag for monoclonal antibodies in colorectal cancer therapyRichard M Goldberg
The Oncologist|October 30, 2015
Genomic Profiling in Gastrointestinal Cancer: Are We Ready To Use These Data to Make Treatment Decisions?Richard M Goldberg
Clinical Colorectal Cancer|June 24, 2004
Current approaches to first-line treatment of advanced colorectal cancerRichard M Goldberg
Nature Reviews. Drug Discovery|June 21, 2005
CetuximabRichard M Goldberg
Pageof 36